Insights into achieving target hemoglobin levels: Increasing the serum ferritin parameter

Dialysis and Transplantation

Volumn 38, Issue 5, 2009, Pages 158-165

  Bralow, Scott ^a  

^a Psychoanalytic Center of Philadelphia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRIC GLUCONATE; FERRITIN; HEMOGLOBIN; IRON;

ANEMIA; ARTICLE; DIALYSIS; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON STORAGE; IRON THERAPY; KIDNEY FAILURE; PRIORITY JOURNAL;

EID: 66249091967     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: 10.1002/dat.20321     Document Type: Article

References (21)

1. KDOQI. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006;47(5 suppl 3):S11-145.
2. Sakiewicz P, Paganini E. The use of iron in patients on chronic dialysis: mistake and misconceptions. J Nephrol. 1998;11:5-15. (Pubitemid 28162358)
3. Brock JH, Halliday JW, Pippard MJ, Powell LW. Iron Metabolism in Health and Disease. 1994; Philadelphia, PA: WB Saunders Company.
4. Centers for Medicare & Medicaid Services. 2007 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards & Quality, Baltimore, Maryland, December 2007.
5. Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant. 2004;19:141-149. (Pubitemid 38072625)
6. Singh AK, Coyne DW, Shapiro W, et al. Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation. Kidney Int. 2007;71:1163-1171. (Pubitemid 46809141)
7. Coyne DW, Kapoian T, Suki W, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol. 2007;18(3):975-984. (Pubitemid 46434515)
8. Petroff S. Evaluating traditional iron measures and exploring new options for patients on hemodialysis. Nephrol Nursing J. 2005;32:65-73.
9. Kosch M, Bahner U, Bettger H, et al. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. Nephrol Dial Transplant. 2001;16:1239-1244. (Pubitemid 32547381)
10. Tarng DC, Huang TP, Chen TW, Yang WC. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int. 1999;69:S107-S118. (Pubitemid 29113591)
11. Kalantar-Zadeh K, McAllister CJ, Lehn RS, et al. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003;42:761-773. (Pubitemid 37187377)
12. Bistrian BR, Khaodhiar L. The systemic inflammatory response and its impact on iron nutriture in endstage renal disease. Am J Kidney Dis. 1999;34(4 suppl 2):S35-S39. (Pubitemid 29473040)
13. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093. (Pubitemid 40007660)
14. Rivera S, Nemeth E, Gabayan V, et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106:2196-2199. (Pubitemid 41291740)
15. Besarab A. Resolving the paradigm crisis in intravenous iron and erythropoietin management. Kidney Int. 2006;69:S13-S18. (Pubitemid 44561638)
16. Cavill I. Iron status as measured by serum ferritin: the marker and its limitations. Am J Kidney Dis. 1999:34:S12-S17. (Pubitemid 29473036)
17. Kopelman RC, Smith L, Peoples L, et al. Functional iron deficiency in hemodialysis patients with high ferritin. Hemodial Int. 2007;11(2):238-246. (Pubitemid 46534559)
18. DeVita MV, Frumkin D, Mittal S, et al. Targeting higher serum ferritin concentrations with intravenous iron dextran lowers erythropoietin requirements in hemodialysis patients. Clin Nephrol. 2003;60:335-340. (Pubitemid 37407691)
19. Chang CH, Chang CC, Chiang SS. Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients. Clin Nephrol. 2002;57:136-141. (Pubitemid 34145198)
20. Kapoian T, O'Mara NB, Singh AK, et al. Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol. 2008;19:372-379.
21. Kalantar-Zadeh K, Regidor DL, McAllister CJ, et al. Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 2005;16(10):3070-3080.